210 results
Page 8 of 11
6-K
EX-99.1
ai2wtc tzgog7s
15 Jan 20
Current report (foreign)
6:06am
6-K
EX-99.1
ufufx gptxc
13 Jan 20
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis
6:06am
6-K
EX-99.1
pdrjt5h95
10 Jan 20
Galapagos to present at 38th Annual J.P. Morgan Healthcare Conference
6:14am
6-K
EX-99.1
9amibg
10 Jan 20
Current report (foreign)
6:13am
6-K
EX-99.1
yheboc52 vm7
20 Dec 19
Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment
6:01am
6-K
EX-99.1
ptyh yb58pewdwwdd
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.1
ym7ixryz
26 Nov 19
Current report (foreign)
6:51am
6-K
EX-99.1
5h4cjepdxxgr4hc
14 Nov 19
Current report (foreign)
6:00am
6-K
EX-99.1
evkp728
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.1
yvxpkmcrfpo
6 Nov 19
Current report (foreign)
4:24pm
6-K
EX-99.1
yopq9p
4 Nov 19
Current report (foreign)
6:00am
6-K
EX-99.1
nm1e90pk3bktwvc
29 Oct 19
MOR106 clinical development in atopic dermatitis stopped for futility
6:00am
6-K
EX-99.1
ytg5vgw2
28 Oct 19
Galapagos receives transparency notification from Wellington Management Group LLP
6:01am
6-K
EX-99.1
qh3wpq m9
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
jda3inxx pb
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.1
9nua7707jk xhb
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.1
p1ipmrose6
8 Oct 19
Galapagos receives transparency notification from Wellington Management Group LLP
6:01am
6-K
EX-99.1
mhf24lz1htrzi2
25 Sep 19
Current report (foreign)
10:50am
6-K
EX-99.1
vjphzo
23 Sep 19
Current report (foreign)
6:00am
6-K
EX-99.1
rxivekv
20 Sep 19
Current report (foreign)
4:07pm